Theravance Biopharma Inc $(TBPH)$ is currently at $9.85, up $0.94 or 10.49%
--Would be highest close since Aug. 1, 2024, when it closed at $10.03
--On pace for largest percent increase since Jan. 3, 2022, when it rose 11.13%
--Currently up six of the past seven days
--Up 19.48% month-to-date
--Down 12.41% year-to-date; on pace for worst year since 2021, when it fell 37.82%
--Down 76.87% from its all-time closing high of $42.56 on July 7, 2017
--Down 3.76% from 52 weeks ago (Nov. 15, 2023), when it closed at $10.23
--Down 15.06% from its 52-week closing high of $11.59 on Jan. 3, 2024
--Up 28.52% from its 52-week closing low of $7.66 on Aug. 9, 2024
--Traded as high as $10.26; highest intraday level since July 31, 2024, when it hit $10.35
--Up 15.15% at today's intraday high; largest intraday percent increase since April 12, 2024, when it rose as much as 16.91%
All data as of 11:53:04 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 13, 2024 11:56 ET (16:56 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.